Telescope Innovations Corp. (TELIF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.82 Million CAD | 942.57% |
| 2022 | -334.75 Thousand CAD | -2039.39% |
| 2021 | -15.64 Thousand CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 849.4 Thousand CAD | 76.92% |
| 2023 Q2 | 625.69 Thousand CAD | 126.28% |
| 2023 Q1 | 276.51 Thousand CAD | -40.43% |
| 2023 FY | 2.82 Million CAD | 942.57% |
| 2023 Q4 | 480.11 Thousand CAD | -24.16% |
| 2023 Q3 | 633.06 Thousand CAD | 1.18% |
| 2022 Q4 | 464.17 Thousand CAD | 0.0% |
| 2022 Q3 | - CAD | 0.0% |
| 2022 Q2 | - CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2022 FY | -334.75 Thousand CAD | -2039.39% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 FY | -15.64 Thousand CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 81.195% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -90825.532% |
| SQZ Biotechnologies Company | 9.79 Million USD | 71.202% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 75.905% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 97.632% |
| Mesoblast Limited | -35.16 Million USD | 108.02% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 8359.18% |
| Genus plc | 178.7 Million USD | 98.422% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -587.653% |
| Marizyme, Inc. | 457.7 Thousand USD | -516.233% |
| ContraFect Corporation | -154 Thousand USD | 1931.5% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 25741.0% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 5741.02% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -3574.405% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -4191.185% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 827.872% |
| MultiCell Technologies, Inc. | 49.32 USD | -5718695.62% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 92.995% |
| EV Biologics, Inc. | 48.9 Thousand USD | -5667.914% |
| Q BioMed Inc. | -8988.00 USD | 31480.841% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 90.018% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 18386.502% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 98.719% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -3929.3% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 2370.01% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -4432.687% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 57056.987% |
| Arch Therapeutics, Inc. | -2439.00 USD | 115742.066% |
| IMV Inc. | -962.29 Thousand USD | 393.102% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -1907.48% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 2992.386% |
| GB Sciences, Inc. | -624.00 USD | 452104.808% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 3378.595% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.963% |
| Halberd Corporation | -208.00 USD | 1356114.423% |
| Enzolytics Inc. | 30.7 Thousand USD | -9084.936% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -107.827% |
| SYBLEU INC | 11.69 Thousand USD | -24015.168% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -484.643% |
| argenx SE | 1.1 Billion USD | 99.746% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 110.933% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -356.849% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 99.311% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 31948.577% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 93.641% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 347.072% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -185.482% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 70.653% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 3463.797% |
| BioStem Technologies, Inc. | 15.42 Million USD | 81.715% |
| ONE Bio Corp. | 20.12 Million USD | 85.985% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 23931.939% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 5944.526% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -1497.48% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -1497.48% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 648.193% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 547.602% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 9825.897% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -526.72% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 982.769% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 38.791% |
| Bioxytran, Inc. | -8285.00 USD | 34143.573% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 856.169% |
| Neutra Corp. | 14.33 Thousand USD | -19575.689% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 3539.646% |
| PureTech Health plc | -1.6 Million USD | 275.952% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 381.703% |
| IXICO plc | 3.27 Million USD | 13.746% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 506.414% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 257.482% |
| CSL Limited | 7.7 Billion USD | 99.963% |
| Cellectis S.A. | 18 Thousand USD | -15569.5% |